Sesen Bio Inc. (SESN) Fundamentals

Sesen Bio Inc is a late-stage clinical company advancing targeted fusion protein therapeutics for the treatment of patients with cancer.
SHARE INFORMATION
Market Cap$ 89,399,606
Shares Outstanding199,463,645
Float199,463,645
Percent Float100.0%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 26,544,000
Latest Fiscal EPS$ -0.09
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions217
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months14,507,160
Institutional Holdings Percent55.4%
Institutional Sold Previous 3 Months31,543,290
Insider Holdings Date2022-03-31
Insider Bought Previous 3 Months2,506,800
Insider Holdings Percent1.5
Insider Sold Previous 3 Months-
Insider Shares Owned2,978,735
TRADING INFO
52 Week High$ 6.04
52 Week Low$ 0.37
52 Week High Change$ -82.35
21 Day Moving Average$ 0.4503
21 Day Extended Moving Average$ 0.468269
50 Day Moving Average$ 0.5505
50 Day Extended Moving Average$ 0.535729
200 Day Moving Average$ 0.952433
200 Day Extended Moving Average$ 1.0309
10 Day Average Volume7,047,671
20 Day Average Volume7,768,517
30 Day Average Volume5,823,746
50 Day Average Volume4,281,214
Alpha0.018899
Beta0.9259
Standard Deviation0.356486
R20.015116
7 Day Price Change$ -0.0336
7 Day Percent Change-6.97%
21 Day Price Change$ 0.0364
21 Day Percent Change8.84%
30 Day Price Change$ -0.0592
30 Day Percent Change-11.67%
Month to Date Price Change$ 0.0681
Month to Date Percent Change17.92%
Quarter to Date Price Change$ -0.1545
Quarter to Date Percent Change-25.63%
180 Day Price Change$ -0.6518
180 Day Percent Change-59.25%
200 Day Price Change$ -0.7618
200 Day Percent Change-62.96%
Year to Date Price Change$ -0.3668
Year to Date Percent Change-45.01%

Sesen Bio Inc. (SESN) Key Ratios

PROFITABILITY
EBIT Margin-156.7%
EBITDA Margin-156.4%
Pre-Tax Profit Margin0.0%
Profit Margin Count3.66%
Gross Margin0.0%
Profit Margin TOT3.66%
INCOME STATEMENTS
Revenue$ 22,234,000
Revenue Per Share$ 0.1115
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.60
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio21.30
Leverage Ratio1.70
Quick Ratio20.30
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio1.60
Enterprise Value$ -87,212,051
Price to Sales4.0209
Price to Free Cash-1.90
PE High Last 5 Years127.00
Price To Book0.50
Price To Cash Flow3.50
PE Low Last 5 Years-2.90
Price to Tangible Book0.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover21.10
Invoice Turnover0.00
Assets Turnover0.10
Return Assets27.06
Return on Equity59.89
Return on Capital59.72

Sesen Bio Inc. (SESN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOThomas R. Cannell
Emplyoees35
Last AuditUQ
CIK0001485003
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address245 First Street
Suite 1800
Cambridge, MA 2142
Websitehttps://www.sesenbio.com
Facsimile-
Telephone+1 617 444-8550
Emailir@sesenbio.com


Your Recent History
NASDAQ
SESN
Sesen Bio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.